1. Pregnancy- Based on studies and methods of action of RETEVMO it is found that when pregnant women take it, it can actively cause fetal harm. So it is not advised to be taken by a pregnant woman or in case of emergency medical specialist advice should be taken. 2. Lactation- There is no data on the presence of Selpercatinib in milk. No data is present on its metabolites in human milk or their effects on the breastfed child or milk production. But because of the potential for serious adverse reactions in breastfed children, it is advised not to breastfeed during treatment with RETEVMO and for 1 week after the last dose in order to avoid ill effects in the baby. To know more about RETEVMO 40 mg price, Call/WhatsApp (+91) 8130290915. We, Ikris Pharma Network, have served more than 50000+ patients in more than 140 countries, making us a reliable dealer for supplying generic drugs. For any query about price or more detail about RETEVMO, Email us at [email protected], and we will reach you as soon as possible.